Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (211-220 of 307) with videos related to

Pageof 31
Sort By:
The Journal of Urology|February 28, 2016
Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and RecurrenceAdam I Cole, Todd M Morgan, Daniel E Spratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2018
Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology GuidelineJustin E Bekelman, R Bryan Rumble, Ronald C Chen, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)Lisa F Newcomb, Yingye Zheng, Anna V Faino, et al.
Histopathology|December 25, 2019
Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literatureEman Abdulfatah, John M Kennedy, Khaled Hafez, et al.
European Urology|September 7, 2020
The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the FutureChristopher J D Wallis, James W F Catto, Antonio Finelli, et al.
Prostate Cancer and Prostatic Diseases|July 21, 2021
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborativeRandy A Vince, Ralph Jiang, Ji Qi, et al.
Nature Reviews. Urology|January 16, 2026
Circulating tumour cells as a window into lethality in prostate cancerSophia M Abusamra, Thineskrishna Anbarasan, Daniele T Cotton, et al.
Asian Journal of Urology|December 22, 2017
Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy seriesZachary B Koloff, Daniel A Hamstra, John T Wei, et al.
The Journal of Urology|October 20, 2020
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing ApproachJeffrey J Tosoian, Bruce J Trock, Todd M Morgan, et al.
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Pageof 31

Showing results (211-220 of 307) with videos related to

Sort By:
Pageof 31
The Journal of Urology|February 28, 2016
Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and RecurrenceAdam I Cole, Todd M Morgan, Daniel E Spratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2018
Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology GuidelineJustin E Bekelman, R Bryan Rumble, Ronald C Chen, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)Lisa F Newcomb, Yingye Zheng, Anna V Faino, et al.
Histopathology|December 25, 2019
Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literatureEman Abdulfatah, John M Kennedy, Khaled Hafez, et al.
European Urology|September 7, 2020
The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the FutureChristopher J D Wallis, James W F Catto, Antonio Finelli, et al.
Prostate Cancer and Prostatic Diseases|July 21, 2021
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborativeRandy A Vince, Ralph Jiang, Ji Qi, et al.
Nature Reviews. Urology|January 16, 2026
Circulating tumour cells as a window into lethality in prostate cancerSophia M Abusamra, Thineskrishna Anbarasan, Daniele T Cotton, et al.
Asian Journal of Urology|December 22, 2017
Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy seriesZachary B Koloff, Daniel A Hamstra, John T Wei, et al.
The Journal of Urology|October 20, 2020
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing ApproachJeffrey J Tosoian, Bruce J Trock, Todd M Morgan, et al.
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Pageof 31